May 14 |
Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress
|
May 14 |
Immatics (IMTX) Reports Q1 Loss, Tops Revenue Estimates
|
Apr 24 |
Wall Street Analysts Believe Affimed N.V. (AFMD) Could Rally 146.73%: Here's is How to Trade
|
Apr 24 |
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
|
Apr 17 |
Affimed N.V. (AFMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
|
Apr 4 |
Does Affimed N.V. (AFMD) Have the Potential to Rally 263.36% as Wall Street Analysts Expect?
|
Apr 1 |
Affimed N.V. (NASDAQ:AFMD) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Affimed N.V. (AFMD) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Affimed GAAP EPS of -€7.09, revenue of €8.28M
|
Mar 28 |
Affimed Reports 2023 Financial Results and Operational Progress
|